Provided by Tiger Fintech (Singapore) Pte. Ltd.

SINOPHARM

21.380
+0.0400.19%
Volume:6.03M
Turnover:128.73M
Market Cap:66.73B
PE:8.64
High:21.500
Open:21.320
Low:21.120
Close:21.340
52wk High:21.500
52wk Low:16.096
Shares:3.12B
HK Float Shares:1.34B
Volume Ratio:0.85
T/O Rate:0.45%
Dividend:0.74
Dividend Rate:3.46%
EPS(LYR):2.474
ROE:7.83%
ROA:2.54%
PB:0.74
PE(LYR):8.64
PS:0.11

Loading ...

Sinopharm Group Stock Rallies 2.2% in Hong Kong

Dow Jones
·
Nov 12

Sinopharm Group Stock Advances 4.0% in Hong Kong

Dow Jones
·
Nov 11

CITIC Securities Maintains "Buy" Rating on SINOPHARM (01099), Q3 Performance in Line with Expectations

Stock News
·
Nov 11

SINOPHARM (01099) Rises Over 3% to Hit Yearly High After Morgan Stanley Sets HK$22.5 Target Price

Stock News
·
Nov 11

Sinopharm (01099) Announces Monthly Share Capital and Issued Shares Update

Bulletin Express
·
Nov 06

Sinopharm Group Co. Ltd. Announces Board Composition Update

Bulletin Express
·
Nov 06

SINOPHARM (01099) Proposes Appointment of Yang Binghua as Executive Director

Stock News
·
Nov 06

Sinopharm Group Announces Executive Director Resignation and Proposed Appointment

Reuters
·
Nov 06

Sinopharm Group Files Director List with HKEX

Reuters
·
Nov 06

Sinopharm Group - Board Proposes Yang Binghua as Executive Director

THOMSON REUTERS
·
Nov 06

Sinopharm Group - Sun Jinglin Resigns as Executive Director

THOMSON REUTERS
·
Nov 06

Shanghai Shyndec Pharmaceutical Continues to Strengthen Cooperation with SINOPHARM in Distribution and Retail Channels

Deep News
·
Nov 05

Sinopharm Group Stock Rallies 1.5% in Hong Kong

Dow Jones
·
Nov 05

Sinopharm Group (SEHK:1099) Valuation in Focus After Reporting Weaker Q3 and Nine-Month Earnings

Simply Wall St.
·
Oct 31

Sinopharm Group (01099) Highlights Third-Quarter 2025 Results of Sinopharm Accord (000028/200028)

Bulletin Express
·
Oct 30

Sinopharm Subsidiary Sinopharm Accord Reports Q3 Revenue Decline

Reuters
·
Oct 30

China National Accord Medicines Q3 Net Profit Down 9.6% Y/Y

Reuters
·
Oct 30

CICC Maintains Outperform Rating on SINOPHARM (01099) with Target Price of HK$24.7

Stock News
·
Oct 29

UOB Kay Hian Upgrades Sinopharm Group to Hold from Sell; Price Target is HK$20

MT Newswires Live
·
Oct 28

Sinopharm Group Co. Ltd. (HKG:1099) Shares Could Be 23% Below Their Intrinsic Value Estimate

Simply Wall St.
·
Oct 28